Stimulation of the B cell receptor, CD86 (B7-2), and the β2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 680-690

  Kasprowicz, Deborah J ^a   Kohm, Adam P ^a   Berton, Michael T ^b   Chruscinski, Andrezj J ^c   Sharpe, Arlene ^d   Sanders, Virginia M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c STANFORD UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CD86 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; TERBUTALINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOGLOBULIN PRODUCING CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0034661979     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.680     Document Type: Article

References (60)

1. Clark, E. A., and J. A. Ledbetter. 1994. How B and T cells talk to each other. Nature 367:425.
2. Fay, T. M., A. Aruffo, J. Bajorath, J. E. Buhlman, and R. J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591.
3. Stevens, T. L., A. Bossie, V. M. Sanders, R. Fernandez-Botran, R. L. Coffman, T. R. Mosmann, and E. S. Vitetta. 1988. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 334:255.
4. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, J. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.
5. Law, C. L., A. Craxton, K. L., Otipoby, S. P. Sidorenko, S. J. Klaus, and E. A. Clark. 1996. Regulation of signaling through B-lymphocyte antigen receptors by cell-cell interactions. Immunol. Rev. 153:123.
6. Croft, M., and C. Dubey. 1997. Accessory molecule and costimulation requirements for CD4 T cell responses. Crit. Rev. Immunol. 17:89.
7. Greenfield, E. A., K. A. Nguyen, and V. K. Kuchroo. 1998. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18:389.
8. Jeannin, P., Y. Delneste, S. Lecoanet-Henchoz, J.-F. Gauchat, J. Ellis, and J.-Y. Bonnefoy. 1997. CD86 (B7-2) on human B cells: a functional role in proliferation and selective differentiation into IgE-and IgG4-producing cells. J. Biol. Chem. 272:15613.
9. Shields, R. W. 1993. Functional anatomy of the autonomic nervous system. J. Clin. Neurophysiol. 10:2.
10. Madden, K. S., V. M. Sanders, and D. L. Felten. 1995. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:417.
11. Wakkach, A., T. Guyon, C. Bruand, S. Tzartos, S. Cohen-Kaminsky, and S. Berrih-Aknin. 1996. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J. Immunol. 157:3752.
12. Zheng, Y., L. M. Wheatley, T. Liu, and A. I. Levinson. 1999. Acetylcholine receptor a subunit mRNA expression in human thymus: augmented expression in myasthenia gravis and upregulation by interferon-γ. Clin. Immunol. 91:170.
13. Felten, D. L., K. D. Ackerman, S. J. Wiegand, and S. Y. Felten. 1987. Noradrenergic sympathetic innervation of the spleen. I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp. J. Neurosci. Res. 18:28.
14. Bulloch, K., and W. Pomerantz. 1984. Autonomic nervous system innervation of thymic related lymphoid tissue in wild-type and nude mice. J. Comp. Neurology 228:57.
15. Williams, J. M., R. G. Peterson, P. A. Shea, J. F. Schmedtje, D. C. Bauer, and D. L. Felten. 1981. Sympathetic innervation of murine thymus and spleen: Evidence for a functional link between the nervous and immune systems. Brain Res. Bull. 6:83.
16. Fuchs, B. A., K. S. Campbell, and A. E. Munson. 1988. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte β-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 117:339.
17. Li, Y. S., E. Kouassi, and J. P. Revillard. 1990. Differential regulation of mouse B-cell activation by β-adrenoceptor stimulation depending on type of mitogens. Immunology 69:367.
18. Shimizu, N., T. Hori, and H. Nakane. 1994. An interleukin-1-β-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats. Brain Behav. Immun. 7:14.
19. Sanders, V. M. 1995. The role of adrenoceptor-mediated signals in the modulation of lymphocyte function. Adv. Neuroimmunol. 5:283.
20. Kohm, A. P., and V. M. Sanders. 1999. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol 162:5299.
21. 2-Adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 148:1822.
22. Sanders, V. M., and A. E. Munson. 1984. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 231:527.
23. Sanders, V. M., and A. E. Munson. 1984. β-Adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 230:183.
24. 2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 158:4200.
25. 2-Adrenergic receptor: a mechanism for selective modulation of Th1 cell cytokine production. J. Immunol. 159:4857.
26. 2-adrenergic receptor gene. J. Biol. Chem. 274:16694.
27. Borriello, F., M. P. Sethna, S. D. Boyd, A. N. Schweitzer, E. A. Tivol, D. Jacoby, T. B. Strom, E. M. Simpson, G. J. Freeman, and A. H. Sharpe. 1997. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6:303.
28. Myers, C. D., V. M. Sanders, and E. S. Vitetta. 1986. Isolation of antigen-binding virgin and memory B cells. J. Immunol. Methods 92:45.
29. Warren, W. D., and M. T. Berton. 1995. Induction of germline γ-1 and ∈ Ig gene expression in murine B cells: interleukin 4 and the CD40 ligand-CD40 interaction provide distinct but synergistic signals. J. Immunol. 155:5637.
30. Snow, E. C., E. S. Vitetta, and J. W. Uhr. 1983. Activation of antigen-enriched B cells. I. Purification and response to thymus-independent antigens. J. Immunol. 130:607.
31. Vitetta, E. S., A. Bossie, R. Fernandez-Botran, C. D. Myers, K. G. Oliver, V. M. Sanders, and T. L. Stevens. 1987. Interaction and activation of antigen-specific T and B cells. Immunol. Rev. 99:193.
32. Leibson, H. J., P. Marrack, and J. W. Kappler. 1981. B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor. J. Exp. Med. 154:1681.
33. Defranco, A. L., E. S. Raveche, R. Asofsky, and W. E. Paul. 1982. Frequency of B lymphocytes responsive to anti-immunoglobulin. J. Exp. Med. 155:1523.
34. Czerkinsky, C. C., L.-A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109.
35. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57:301.
36. Lefkovitz, I., and H. Waldmann. 1979. Limiting Dilution Analysis of Cells in the Immune System. Cambridge University Press, Cambridge.
37. Freeman, G. J., F. Borriello, R. J. Hodes, H. Reiser, K. S. Hathcock, G. Laszlo, A. J. McKnight, J. Kim, L. Du, D. B. Lombard, et al. 1993. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907.
38. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
39. Lenschow, D. J., G. H. T. Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90: 11054.
40. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 binding counter-receptors which costimulate T cell activation. Proc Natl. Acad. Sci. USA 90:11059.
41. + T cells. Eur. J. Immunol. 25:1992.
42. Lenschow, D. J., A. I. Sperling, M. P. Cooke, G. Freeman, L. Rhee, D. C. Decker, G. Gray, L. M. Nadler, C. C. Goodnow, and J. A. Bluestone. 1994. Differential up-regulation of B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990.
43. Chen, C., A. Gault, L. Shen, and N. Nabavi. 1994. Molecular cloning and expression of early T cell costimulatory moelcule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929.
44. Chen, C., and N. Nabavi. 1994. In vitro induction of T cell anergy by blocking B7 and early T cell costimulatory molecule ETC-1/B7-2. Immunity 1:147.
45. Zelazowski, P., D. Carracso, F. R. Rosas, M. A. Moorman, R. Bravo, and C. M. Snapper. 1998. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline C-H transcription and Ig class switching. J. Immunol. 159:3133.
46. Robbing, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387.
47. Fine, D. P., J. L. Kirk, G. Schiffman, J. E. Schweinle, and J. C. Guckian. 1988. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3. J. Lab. Clin. Med. 112:487.
48. Luster, M. I., C. Portier, D. G. Pait, G. J. Rosenthal, D. R. Germolec, E. Corsini, B. L. Blaylock, P. Pollock, Y. Kouchi, W. Craig, et al. 1993. Risk assessment in immunotoxicojogy. II. Relationships between immune and host resistance tests. Fund. Applied Toxicol. 21:71.
49. Luster, M. I., C. Portier, D. G. Pait, Jr. White, K.L., C. Gennings, A. E. Munson, and G. J. Rosenthal. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fund. Applied Toxicol. 18:200.
50. Ader, R., D. Felten, and N. Cohen. 1990. Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30:561.
51. Dono, M., V. L. Burgio, C. Tacchetti, A. Favre, A. Augliera, S. Zupo, G. Taborelli, N. Chiorazzi, C. E. Grossi, and M. Ferrarini. 1996. Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur. J. Immunol. 26:2035.
52. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233.
53. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
54. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
55. Hasbold, J., A. B. Lyons, M. R. Kehry, and P. D. Hodgkin. 1998. Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. Eur. J. Immunol. 28:1040.
56. Linehan, L. A., W. D. Warren, A. P. Thompson, M. J. Grusby, and M. T. Berton. 1998. STAT6 is required for IL-4-Induced germline Ig gene transcription and switch recombination. J. Immunol. 161:302.
57. Shields, J. G., K. Kotowicz, and R. E. Callard. 1992. Interleukin-4 stimulates immunoglobulin secretion by Epstein-Barr virus (EBV)-activated tonsillar B cells, and by EBV-transformed lymphoblastoid B cell lines without increasing cell division. Int. J. Clin. Lab. Res. 22:95.
58. 2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human. Mol. Immunol. 30:157.
59. 2-adrenoceptor agonist, fenoterol. Eur. Respir. J. 9:220.
60. + Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J. Immunol. 165:725.